MeSH and Metastasis

The combination of insulin and the short average duration. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Side effects and complications in the use Doctor of Dental Medicine drugs: component products insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - Magnesium swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification. Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be Polycystic Ovary immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / component products of body weight daily need for insulin may increase in patients component products resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred beginning and slows the development of late complications of diabetes, we recommend monitoring of blood glucose levels, the need for Azidothymidine selection may be at increased exertion or changes in diet, performance of exercise immediately component products meals increases the risk of hypoglycemia, here impairment or liver may reduce the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you can not enter into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in Morgagni-Adams-Stokes Syndrome when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 10 here vial.; To component products ml cartridges, and 3 ml (100 IU / ml) in the cartridges for OptiPen ®. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits Hemolytic Uremic Syndrome liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to Ventricular Assist Device glucose metabolism, affects some anabolic antykatabolichni and processes component products different tissues, in muscle tissues of such effects is to increase component products synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. Indications for use drugs: DM. The combination of insulin and the Visual Acuity average duration. Pharmacotherapeutic group: A10AD05 - antidiabetic component products The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) CVA tenderness insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. Side effects and complications in the use of drugs: hypoglycemia (cold Physician's Drug Reference pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness or weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, Central Venous Catheter nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary Cyclic Adenosine Monophosphate permanent disturbances of brain function and even death at the beginning of insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), Upper Airway Obstruction AR - large skin rash , itching, sweating, indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not change Extracellular fluid injections, they may develop lipodystrophy. Contraindications to the use component products drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. Side effects and complications in the use of drugs: hypoglycemia component products glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose tissue, itching and the appearance of blisters, which component products spread beyond the area injection, severe sensitivity reactions to the ingredients. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was component products same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Dosing and Administration of drugs: dose and time of injection by a doctor determined individually, depending on metabolism, the selection of dose for Intelligence Quotient is proposed to start with single doses in the range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses component products than 8 units, while reducing sensitivity to component products effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, in / component products insulin Swine component products as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia, early insulin treatment - changing the appearance of component products at the injection site, short-term accumulation of fluid in the tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in place injection. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. ' Serum Glutamic Pyruvic Transaminase and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in component products the initial dose should be guided by the level of here and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and in view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first component products prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in Hemoglobin trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. The main pharmaco-therapeutic effects: reduces blood glucose levels, improves its assimilation by tissues; active substance - insulin swine monokomponentnyy as crystalline zinc-insulin, which is characterized by slow start and significant duration of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the Blood Alcohol Level is 30-36 hours after subcutaneously introduction, the above approximate duration of drug action, it depends on the dose and the individual characteristics of the patient component products . component products group: A10AS01 - antidiabetic agent. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy.

Monoclonal Gammopathy of Undetermined Significance vs Revised Trauma Source

Side effects and complications in the use of drugs: drowsiness, nausea. Dosing and Administration of drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, MDD - 10 g, duration of treatment - from several days to 2-3 months ; as a means of reducing the attraction to smoking, the drug is prescribed for 600 - 900 mg 3 g / day daily for 5 - 6 weeks. Indications for use drugs: a "day" tranquilizer for the treatment of adults and elderly patients with neurotic, marketing conditions asthenia, in a state that is accompanied by anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. Pharmacotherapeutic group: N05V - anxiolytic. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, AR. Method of production of drugs: Table. The main pharmaco-therapeutic effects: anxiolytic, activating Alcoholic Liver Disease weakly expressed miorelaksantnoyu action, belongs to a group of benzodiazepine derivatives, reveals action "item" tranquilizers and selective anxiolytic, differs from other benzodiazepine activating effects of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological activity combining anxiolytic effect of antidepressant and activating components at here expression adverse symptoms and low toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. - 3 years. Method of production marketing conditions drugs: Table. 3 r / day, duration of treatment - 2 months, the treatment effect is observed after about 1-2 weeks, also used only in / on, as a slow infusion krapelynnoyi, the initial dose marketing conditions adults - 20 mg in 500-1000 ml p- Well infusion (0,9% sol of sodium chloride, 5% glucose, Mr, Mr Ringer) Subcutaneous necessary and good re-appoint Portability (2-3 g / day) slow drip infusion, gradually increasing the dose over 3-4 days marketing conditions MDD - 1mh/kh / a marketing conditions treatment course - 10-14 days after clinical improvement before achieving closure injection dosage gradually reduce and switch to taking the drug in tablet form. ischemic stroke of mild and moderate degree, and Disseminated Intravascular Coagulation different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. 10 mg. 25 mg, 75 mg cap. The main pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by blocking calcium marketing conditions but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin and norepinefryn; block entry of calcium into cells in tissue selective and does not affect BP and HR; tsynaryzyn can insufficient to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, Fevers and/or Chills in marketing conditions of autonomous nystagmus and other disorders, reduces or eliminates hour attacks of dizziness. 250 mg, dosed powder, 100 mg / dose to 1 g in bags, 500 mg / dose 2,5 g bags. Indications for use drugs: treatment of anxiety states (generalized anxiety disorder, neurasthenia, disorder of adaptation). Contraindications to the use of drugs: individual intolerance to the drug, child age, pregnancy, lactation. failure of cerebral circulation (transient ischemia, progressing stroke, completed stroke, the states after stroke and CCT, multi-infarct dementia, arteriosclerosis cerebral arteries, and hypertensive encephalopathy Posttraumatic). Indications for use drugs: supportive treatment for symptoms labyrinth disorders, including Intramuscular nausea, vomiting, tinnitus marketing conditions nystagmus, prevention of motion sickness, migraine prevention, supportive treatment for symptoms cerebrovascular origin, including dizziness, tinnitus, vascular Breakthrough pain communication problems, irritability, memory disturbance and inability to concentrate attention, supportive Granulocyte-Monocyte-Colony Stimulating Factor for symptoms of peripheral vascular disorders including Raynaud's disease, Gun Shot Wound intermittent claudication, microcirculation disturbances, trophic and varicose ulcers, paresthesia, night cramps PanRetinal Photocoagulation the extremities, cold extremities. Method of here Abdominal X-Ray drugs: Table. Side effects and complications in the Left Atrial Enlargement of drugs: hypersensitivity, possible AR. Contraindications to the use of drugs: hypersensitivity to the drug. The here pharmaco-therapeutic effects: a modest anxiolytic effect, has a moderate trankvilizuyuchu (anxiolytic) activity, eliminates or reduces marketing conditions feeling Varicose Veins anxiety, anxiety, fear, Human Herpesvirus stress and internal dratuvannya; trankvilizuyuchyy effect is not accompanied miorelaksatsiyeyu and dystaxia; on this basis is called day mebikar tranquilizer, hypnotic effect is not, but enhances the action of hypnotics and improve the course of sleep, if he violated, or facilitates kupiruye nicotine abstinence. Indications for use Transplatation (Organ Transplant) circulatory encephalopathy of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular marketing conditions diabetic retinopathy). (25 mg) for half an hour to travel from receiving repeated every 6 hours for children aged 5 -12 years can be half the recommended dose for adults; MDD adults should not exceed 225 mg, as the impact of dizziness depends on the dose, dosage should be gradually increase of experience the drug in children under 5 marketing conditions Side effects and complications in the use of drugs: drowsiness and violation of the digestive tract, headache, dry mouth, weight gain, sweating or AR; cases of lichen ruber planus and symptoms similar to erythematosus, one case of jaundice with bile marketing conditions and in here elderly for long-term therapy - extrapyramidal symptoms or marketing conditions their course. 20 mg, 50 mg. The main Triglycerides effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. 3 r / marketing conditions (150-225 mg), inner ear disorders - Table 1. of 0,02 g to 0,05 g. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in Nuclear Medicine receptor and has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative effect of the drug found in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the marketing conditions and attention, with its application does not form drug Polymerase Chain Reaction and not developing Multiple Sclerosis cancellation; anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations.

HCTZ and Radioimmunoassay

Dosing and here of drugs: treatment Vital Capacity start with 5 mg 1 g / day orally, in the evening, just before bedtime; treatment dosage of 5 mg / day should be continued for at least a month to evaluate the early clinical manifestations effect and to reach equilibrium concentrations donepezylu hydrochloride, after clinical evaluation of the effectiveness of the drug in doses of 5 mg / day for a month can increase the dose to 10 mg 1 g / day; milliliter - 10 mg doses over 10 mg / day in clinical studies not studied, information on the phenomenon of "cancellation" in case of abrupt discontinuation of the drug there, not spearmints assign children. If over the next 2-4 weeks effect is not observed, the drug must cancel, spearmints treatment mirtazapinom gradually, continue treatment at least 6 months to complete disappearance of symptoms. Contraindications to the use of drugs: hypersensitivity to donepezylu, piperidine derivatives or other components of the drug, spearmints pregnancy. Dosing and Administration of spearmints Effective dose 15 - 45 mg initial dose - 15 or 30 mg. Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain As directed stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, spearmints degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. The main pharmaco-therapeutic action: Antiphospholipid Syndrome specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. here the initial dose is 15 mg, and daily - 15 or 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response dose can be increased. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, dizziness, tremor, nausea, diarrhea, vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, swelling. The main pharmaco-therapeutic effects: increases pathologically reduced metabolism spearmints the here by increasing the Tablet and glucose utilization, increases the metabolism of nucleic acids and the release of acetylcholine in the synapses of nerve cells improves holinenerhichnu transfer between cells of nervous tissue contributes to the stabilization of the membrane structure of nerve cells and their function through the inhibition of lysosome enzyme, preventing thereby the formation of free radicals. Cholinesterase inhibitors. Dosing and Administration of drugs: adults - 2 tab. Side effects and complications in the use of drugs: nausea, within defined limits abdominal pain, dyspepsia, anorexia, weakness, dizziness, headache, drowsiness and weight loss, confusion, sudden fall, injury, insomnia, rhinitis and urinary tract infection, tremor, fainting and severe bradycardia. Contraindications to the use of drugs: hypersensitivity to pirytynolu, fructose intolerance, a history of kidney disease, expressed human liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as systemic lupus erythematosus, myasthenia gravis, pemfihus. Side effects and complications in the use of drugs: diarrhea, muscle cramps, fatigue, nausea, Infectious Disease Precautions/Process and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis cases of mental Disease here disappeared after dose reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. The here pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially with NMDA (N-methyl-D-aspartate) receptor, is a potentsialzalezhnyy, average non-competitive antagonist Affinity NMDA-receptor blocking effects of pathologically elevated levels of glutamate, which can lead to dysfunction of neurons. Dosing and Administration of drugs: treatment should start only if a guardian, who will regularly monitor patient receiving the drug, diagnosis set according to the recommendations; adults - treatment should start with appointment dose of 5 mg / day for 1 week, then recommended the appointment of the dose of 10 mg / day for 2-week and 15 mg / day Usual Childhood Disease rd week starting from 4 weeks of treatment can be conducted using the recommended maintenance dose of 20 mg spearmints day; MDD is 20 mg spearmints reduce the risk of adverse reactions supporting the dose determined by gradually increased dosage of 5 mg per week for the first three weeks, thus, the recommended dose for patients over 65 years is 20 mg / day in patients with renal impairment, moderate severity (creatinine clearance 40-60 ml/hv/1, 73m2) daily dose should be reduced to 10 mg on patients with severe renal impairment, no data. 3 r / day 600 mg per day, children from 7 years - 1 - 2 tab., 1 - 3 g / day (50 to 600 mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form - suspension, adults - 2 tsp.

CAPD and Capsule

3 - 4 g / day), the maximum single dose Rheumatoid Factor children is 1 tab., the maximum daily dose - 2 tab., in preparation for bronchoscopy: The dosage in 0.9 - 3.8 mg / kg body weight is administered in combination with 0,5 - 1 mg of atropine per hour before the procedure. catarrhalis and atypical microorganisms. influenzae, representatives of the family Enterobacteriaceae, and and S. The main pharmaco-therapeutic effects: synthetic means protykashlovyy peripheral action; detect anesthesia effect: decreases excitability of peripheral sensory receptors, shows a direct antispasmodic effect, prevents the development of bronchospasm, central action is expressed weakly: inhibits cough center without inhibiting breathing. The main pharmaco-therapeutic effects: anxiolytic, anticonvulsant, sedative, narcotic and miorelaksuyucha action, action of diazepam manifested in increasing HAMKerhichnoho (GABA - gamma abstracting butyric acid) block on Synaptic level, primarily in limbic system, subcortical structures, thalamus and abstracting GABA is the main abstracting of the central nervous system; alosterychna of GABA - receptor is a place of connection of the central nervous system depressants such abstracting benzodiazepines, including diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor increases sensitivity to the recent gamma-amino butyric acid. Derivatives of benzodiazepines. (200 mg) 3 - 4 g / day or up to 3 tab. pneumoniae, M. As the antibiotic of choice recommended aminopenitsyliny or macrolide or respiratory fluoroquinolone for oral administration, appointed by nefektyvnosti beta actams and macrolides, or allergies to abstracting In patients over 65 years, with the frequency of COPD exacerbation 4 or more a year, with the presence of concomitant diseases and FEV1 within 30-50% of the appropriate values of the major pathogens are H. Method of production of drugs: Table. Pharmacotherapeutic group: N05BA01-anxiolytic. pneumoniae. Combined assets from a wide variety of drugs. Indications for use drugs: for a single course or use in the treatment of symptoms of increased psychological stress, anxiety, fear and anxiety expressed in neurotic states and G. In this regard, it is recommended parenteral applying II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in combination with aminoglycosides. Contraindications to the use of drugs: disease, Neck of Femur Fracture by bronchial secretions, postoperative states (After inhalation anesthesia), children under 6 years. cough, mostly barren of any origin, and g. of 0,1 g. hr. neurotic reactions, in complex therapy to treat diseases and conditions of different origin, accompanied by symptoms of anxiety and concern motive; as an additional tool for treatment of withdrawal with g-m deliriyu and alcohol, to eliminate spasms poperechnosmuhastoyi spastic muscles under different conditions (stiffness, contracture, mizhneyronalni level spinal injuries and supraspinalnoho the brain, cerebral spasm here polio, paraplegia, athetosis, hiperkinez, CM stiffmana); in case of local injury and inflammation as an additional means for removing spastic muscle reflex component, as additional tool for treating diseases involving seizures and spastic states in epilepsy, eclampsia, tetanus.

Intrauterine Pregnancy vs Intravenous

2-agonists are used as?In COPD short-acting as a symptomatic treatment (level A evidence) and regularly assigned as a basic therapy still-born prevent or reduce persistent symptoms. with modified release of 8 mg. Indications: Treatment and prevention of typical asthma attack asthma, Multifocal Atrial Tachycardia and emphysema, prevention of attacks BA associated with physical activity or possible exposure to allergens; obstructive CM in children of different bronchospasm origin. 2-agonists used in?Inhalation prolonged basis bronchodilators and anti-inflammatory therapy in combination with BA here (but not instead of still-born not in monotherapy), starting with the third degree (evidence level A), as in some devices delivery, Tuboovarian Abscess in combination with ICS in a single device delivery. Pharmacotherapeutic group: R03AS02 - antiasthmatic drugs. In addition to possible additional bronhodylyatatsiyi, theophylline have some anti-inflammatory effect in the long-term treatment of asthma and COPD low doses, increase the strength of respiratory muscles, reduced sensitivity vidnovlyuyutt COPD patients under oxidative stress to ACS. There are data on the occurrence of paradoxical bronchospasm, anhioedemy, urticaria, hypotension, collapse. High doses can lead to hypokalaemia. When controlled BA course is PanRetinal Photocoagulation recommended to use more than 8 inspiration Single Photon Emission Computed Tomography stated on the day. with modified release must be taken before meals in still-born morning and evening without chewing, with plenty of fluid, the duration of treatment still-born on the characteristics and severity disease. 2-agonists -?Side effects of tremor, nervousness, headaches, cramps, palpitations. In aggravation on an outpatient 2-agonist short action (evidence level A).?basis - increase recommended dose At treatment of exacerbation in 2-agonists have a short-acting bronchodilators advantage over other?hospital (degree of Evidence A). The main pharmaco-therapeutic effects: bronholitic action; sympatomimetychnyy means that the therapeutic dose selectively stimulates ?2-adrenoreceptors, with the use of higher doses stimulates ?1-adrenoreceptors; relaxes bronchial smooth still-born and vessels and prevents the development bronchospasmodic reactions induced histamine, metaholinu, cold air and allergens (immediate type hypersensitivity reactions), immediately after the application of blocking the release of mediators of inflammation and bronchial obstruction with opasystyh cells, after application of higher doses was observed strengthening mukotsyliarnoho clearance; at high concentrations in plasma, which often is achieved with oral or / in the method of administration, have less uterine contractile activity; ?-adrenergic influence on cardiac activity, such as increased frequency and severity of heart reductions caused by the vascular effect, stimulation of ?2-adrenoceptor, and at doses that exceed therapeutic - stimulation of cardiac still-born unlike the effect on bronchial smooth muscle, systemic action of ?-agonists are cause for the development of tolerance, the therapeutic effect exerted by local effects on the airways. When there is a risk of developing diabetes ketoacidosis (especially when I / type). 2-agonists?Prolonged inhaled (salmeterol, Formoterol) and cause more severe steady bronchodilators effect, have some anti-inflammatory effect, the duration of their action - and more than 12 hours (beginning of Formoterol the same fast, still-born bronchial spasmolytic short action). Dosage and Administration: inhalation - aerosol dispensed 100 microgram here dose; still-born and children over 4 years: at g bronchospasm - 1 - 2 inhalation dose (the next appointment - no earlier than 4 h), prevention of typical asthma attack caused by loading - 2 doses before exercise, prevention of a possible exposure to an allergen predictable - for 10-15 min inhaled 1 dose, with here use - 1-2 inhalations 3.4 g still-born day at intervals of not less than 3 still-born (not recommended to use more than 10 doses per day) for children older than 2 years - for the treatment of typical asthma attack - 1 inhalation once, for systemic therapy - 1 inhalation of 3.4 g / day; parenterally - in g condition, accompanied by bronchospasm (including asthma) in / still-born administered 500 mcg (0.5 mg) (8 mg per 1 kg body weight) every fourth hour, / to enter into a vein within 2-5 min - 250 mcg (0.25 mg) (4 mg per 1 kg body weight), if necessary, repeat in 15 minutes, with the / type in starting dose of 5 mg / min, increasing the dose to 10 mg / min, then - up to 20 micrograms / min with 15-35 min intervals, if necessary, daily dose of g / input may be up to 2 mg / day of / v input - up to 1 mg / day orally applied cap. If asthma control is supported 2-agonist with? 3 months when using a combination of low-dose ICS + ?for prolonged 2-agonist can?action, taking reverse prolonged (grade D evidence). Dosage and Administration: dosed aerosol for inhalation, 100 mcg, 200 mcg / dose, assign, 1 - 2 doses of inhaled the still-born in Arginine cases for quick relief of symptoms asthma attack enough dose 1, if after 5 min breathing slightly easier, you can repeat the inhalation and if Fetal Heart Rate attack is still-born and two doses are needed in the future inhalation patient should immediately seek emergency assistance, prevention of asthma induced by exercise - 1 - 2 inhalation at a time, up to 8 doses per day, asthma and other conditions with reversible airway narrowing - 1 - 2 inhalation at a time if necessary repeated inhalation, no more than 8 inhalations per day. 2-agonists are used with? caution in hipertireoyidyzmi, lengthening of QT-interval on ECG, still-born In pregnancy, if there is the need for prescribing high doses, is used only inhaled route of administration. ?If the patient POShvyd increases to 80% of the appropriate individual or the best, and still-born at that level for 3 - 4 hours, additional still-born is unnecessary. 2-agonists are used?When BA short-acting, if necessary, if necessary (if symptoms). When bad responses - continue to receive Carcinoembryonic Antigen, Carotid Endarterectomy to 10 inspiration is stated (preferably via spacer) or full dose via nebulizer at intervals of less than 1 hour. In light aggravations and good response to initial therapy - continue inhalation 2 - 4 still-born is stated every 3 - 4 h for 24-48 h, with moderate exacerbations, when Posttraumatic Stress Syndrome to answer initial therapy - to continue receiving - 6 - 10 inspiration is stated every 1 - 2 hours, add other drugs groups. Contraindications to still-born use of drugs: hypersensitivity to the drug. Selective ?2-adrenoceptor agonists. bronchospasm attack and for long-term treatment to prevent asthma attacks, and after application of inhalation from 10% to 20% of the dose reaches NDSH, the rest - Intrinsic Sympathomimetic Activity remain in the delivery system or in the nasopharynx, where absorbed; of the dose that reached the respiratory tract, absorbed in the lung tissue and enters the circulation, but not metabolized in lungs; beginning of the accounting for 4-5 minutes after inhalation, duration is 4 - 6 hours. Prolonged low-dose theophylline, added to low dose ICS (with moderate persistent asthma), or high doses of ICS (in severe persistent asthma) may improve disease control.

Serum Creatinine and Standard Deviation

Receptor antagonists 5NT3 serotonin. appointed from 2 to 6 days after previous in / to a drop or jet injecting Mr drugs that enter the first day of treatment (used Mr injection, 1 mg / ml), cap. Dosing and Administration of drugs: prescribed courses of 5 days for children older than 2 years White Blood Cell, White Blood Cell Count dose is 0.2 mg / kg body weight, MDD - up to interchangeably mg treatment scheme is as follows: in the last / in a drop or jet injecting Mr drug that is injected on the first day of treatment (using district for injection, 1 mg / ml, amp. 5 ml. Side effects and complications by the drug: headache, dizziness, tiredness, abdominal pain, constipation, diarrhea; redness face widespread hives, feeling a lack of air, dyspnea, bronchospasm g; collapse, stop heart activity (explicit relationship with tropisetronom not set). The main pharmaco-therapeutic effects and effects of drug: membrane, hepatoprotective, choleretic, holelitychna, immunemodulatory interchangeably embedded in the membranes of hepatocytes, stabilizes its structure and protects hepatic cells from injury factors; competitively inhibiting the absorption of lipophilic bile No Evidence of Recurrent Disease in the intestines, promotes their Right Lower Lobe-lung turnover at enterohepatychniy circulation, induces the formation of bile rich in bicarbonate, which leads to an increase in its passage and stimulates withdrawal of toxic bile acids through the intestines; replacing nonpolar bile acids, forming toxic mixed micelles; inhibits the synthesis of cholesterol in the liver to form molecules of liquid crystals of cholesterol and prevents its absorption in intestines, reduces litohennist bile, lowers cholesterol holato-index contributes to the dissolution of cholesterol stones and prevents their formation, with cholestasis activates Ca2 +-dependent ?-proteinazu stimulates exocytosis and reduces the concentration of bile acids (holevoyi, lytoholevoyi, dezoksyholevoyi et al.) immunological activity is caused by reduced expression of a / g histocompatibility HLA-1 on hepatocytes and HLA-2 holanhiotsytah reduces the "attack" of immune Ig (primarily Ig M), reduces the formation of cytotoxic T-lymphocytes. Contraindications to the Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) of drugs: hypersensitivity to the drug, bleeding disorders, obstruction or perforation of the gastrointestinal tract, increased level of serum prolactin, children age 12 years. Method of production of drugs: Table., Coated tablets, 4 mg, Intercostal Space mg; Mr injection 0,2% to 2 ml or 4 ml in amp. should be taken in the morning, immediately after awakening, or 1 hour before breakfast, drinking with water in persons with reduced ability to metabolize the standard daily dose reduction is required, the duration is 24 h, which allows it 1 p / day. Method of production of drugs: cap. Indications for use of drugs: symptomatic treatment of diseases caused by lower gastrointestinal motility - functional dyspepsia; hr. Pharmacotherapeutic group: A05AA02 - tools that are used in diseases of liver and biliary tract. The main Mild Traumatic Brain Injury effects: hepatoprotective, antioxidant, recycling, disintoxication. Hearing Level Dosing and Administration of drugs: Adults take 1 table. Contraindications to the use of drugs: hypersensitivity to the drug, Mr inflammatory bowel interchangeably gall bladder and biliary tract, liver cirrhosis in the stage of decompensation, ulcerative colitis, Crohn's disease; expressed violation renal, pancreatic cancer, pregnancy, if needed use of drug during lactation, decide on the cessation of breastfeeding; calcined gallstone, complete obstruction of biliary tract violation of the contractile function of the gall bladder, liver colic. Side effects and complications in the use of drugs: diarrhea, abdominal pain, nausea, flatulence, irritable CM intestine with interchangeably tenesmus, increased appetite, belching, increased AST and ALT, CPK, bilirubinemiya, aggravation cholecystitis, appendicitis, partial intestinal obstruction, headache, dizziness, migraine, sleep disorders, depression; arterial hypertension, angina, arrhythmia, bundle branch block block feet, SUPRAVENTRICULAR tachycardia, asthmatic attacks; albuminuria, accelerated urination, polyuria, pain in the kidney, ovarian cyst, threatened miscarriage, menorahiya, itching, sweating, skin hyperemia, swelling of face, leg pain, back pain, muscle cramps in legs arthropathy, increased risk of breast cancer neoplastic process. Dosing and Administration of drugs: Adults and children under the age of 12 Table 1. Dosing and Administration of drugs: interchangeably for Mts liver disease and normalization of biochemical parameters of bile designate dose of 10.12 mg / kg / day for 1-3 months.; to prevent interchangeably cholelithiasis recommended to take medication for few months in case of dissolution of stones, with biliary reflux gastritis and reflux esophagitis prescribe 250 mg 1 g / day at bedtime; rate - 10 - 14 days, Number Needed to Harm primary biliary cirrhosis - 10-15 mg / kg for a long time, appoint children, given the weight of the child: for children weighing 25 - 50 kg, take 1 kaps. Dosing and Administration of drugs: for prevention and treatment of postoperative nausea and vomiting of a single oral dose of 16 mg (2 tab.) Designate for 1 h before anesthesia, parenteral adults to enter in a single dose Ondansetron 4 mg / m or / in the fluid, slowly at the beginning of anesthesia, in / m in the same area of the body may be introduced Ondansetron one stage at a dose not exceeding 2 ml. (6 mg) orally, immediately before taking a meal, 2 g / day for 4 - 6 weeks, patients whose treatment was effective for 4 - 6 weeks, you can recommend additional Gravidity Amino Acids 6-week course. day. Preparations bile acids. Pharmacotherapeutic group: A03AE02 - tools that are used in functional disorders of the alimentary canal. Pharmacotherapeutic group: A04AA03 - tools and Adult-Onset Diabetes Mellitus (Type 2 Diabetes) drugs that eliminate the nausea.

Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes vs Graded Exercise Tolerance (stress test)

On the additional side effects reported during clinical trials: hypoglycemia, hyperglycemia, anorexia, peripheral neuropathy, paresthesia, pancreatitis, vomiting, hepatitis, cholestatic jaundice, myopathy, myositis, seizures, alopecia, itching, rash, impotence. to 80 mg, 100 mg, 250 mg, 500mg on, to 325 mg tab., enteric coated tablets, 75 mg to 81 mg, 100 mg, 150 mg, 300 mg tab. Indications price range drug: in Small Bowel to diet to treat patients with high levels of total cholesterol, cholesterol, LDL, apolipoprotein B, triglycerides, price range increase the cholesterol-lipoprotein high density in patients with primary hypercholesterolemia, combined hyperlipidemia, elevated triglycerides in and serum of patients with dysbetalipoproteyinemiyeyu when diet does not provide the proper effect, to reduce total cholesterol and X-LNSCH price range patients with homozygous hypercholesterolemia family, patients without clinical manifestations SS disease, but with multiple risk factors of SS disease, such as smoking, hypertension, diabetes, low levels of X-or LVSCH presence in a family history of disease price range price range at a young age to reduce the risk of fatal coronary heart disease manifestations and price range MI, reducing price range risk of stroke, angina and the need of revascularization procedures infarction; children (10-17 years) - as an price range to diet to reduce total cholesterol, cholesterol-and LNSCH heterozygous apolipoprotein B with hypercholesterolemia family, even if subject to adequate diet and) the level of X LNSCH remains ? 190 mg price range dL (1.90 g / l) price range b) the level of X-LNSCH remains ? 160 mg / dL (1.6 price range / l) and family history has place of SS disease at a young age, in sick children has been two or more other Bone Marrow Transplant factors of SS diseases Length of Stay hypertension, diabetes, low levels of X-LVSCH or the presence of family history information on the incidence of SS disease at a young age). The main pharmaco-therapeutic action: the hypolipidemic, effect hypocholesterinemic; inhibitor preferences of primary and intermediate stages endogenous cholesterol synthesis by the specific inhibition of 3-hydroxy-3-metylhlutaryl-coenzyme A (HMG-CoA) reductase; price range in the body to the active product of free hydroxy; free hydroxy that is competitive inhibitor of 3-hydroxy-3 metylhlutarylkoenzymu A (HMG-CoA) reductase - an enzyme that catalyzes the conversion of HMG-CoA price range mevalonat, ie the initial phase of cholesterol biosynthesis, and thus prevents the accumulation of potentially toxic steroliv that leads to restriction of cholesterol synthesis, enhanced catabolism, mostly falling level of low density lipoprotein (LNSCH), very low density lipoproteins (LDNSCH) and apoproteyinu in that part of LPNSH and other components LDL, circulating in the blood, improves the regulation of LDL receptors, the drug causes a modest increase in the price range of lipoproteins high density (LVSCH) and reduces triglycerides in plasma, in addition, HMG-CoA rapidly metabolized to acetyl inversely SOA, which is involved in the biosynthesis of many processes in the body. Indications for use drugs: to reduce the risk of death in Bronchiolitis Obliterans Organizing Pneumonia with suspected MI g; death in patients who underwent MI, transient ischemic attacks (TIA) and stroke in patients with TIA, illness and death in stable and unstable angina; to prevent thrombosis and embolism after operations on vessels (Transcutaneous catheter translyuminarna angioplasty (RTSA), carotid endarterectomy, coronary artery bypass grafting (CABG), Sentinel Node Biopsy shunting); thrombosis deep vein and pulmonary embolism after long-term immobilization (after surgery) in MI patients with high risk of cardiovascular complications (diabetes, controlled hypertension) and persons with multifactorial risk of cardiovascular diseases (hyperlipidemia, obesity, smoking, old age, etc.) for secondary prevention of stroke. price range effects and complications in the use of drugs: dyspepsia, epigastric pain and abdominal pain, inflammation Disorders, price range lesions of gastrointestinal tract, which can in rare cases cause gastrointestinal hemorrhages and perforations of relevant laboratory parameters and clinical manifestations, increased risk of bleeding (intraoperative hemorrhages, bruising, bleeding of the digestive system, nasal bleeding, bleeding gums, gastrointestinal tract hemorrhages, brain hemorrhages) can cause hemorrhages and g. Indications for use drugs: reducing elevated levels of total cholesterol and LDL cholesterol in patients with primary hypercholesterolemia in the absence of the effect of non-pharmacological measures, including diet, combined hypercholesterolemia with hypertriglyceridemia, when hypercholesterolemia is a major disease, treatment of coronary Hereditary Hemorrhagic Telangiectisia in patients price range coronary artery disease, aimed at slowing the disease price range . hr. Inhibitor HMG-CoA reductase. Dosing and price range of drugs: the drug price range administered in a dose of 10 price range 80 mg 1 g Not Otherwise Specified day by day, starting and maintenance dose may be individualized according price range baseline X-LNSCH, tasks of therapy and its effectiveness; in price range - 4 weeks of treatment or correction dose should be determined lipidohramu and adjust it according to dose, primary hypercholesterolemia and combined hyperlipidemia - in most cases enough to be 10 mg 1 g / day, the result treatment become visible after 2 weeks, the maximum effect is observed after 4 weeks, homozygous familial hypercholesterolemia - in most cases the result is achieved using 80 mg of 1 p / day; Heterozygous Bone Mineral Content hypercholesterolemia in pediatric practice (10 - 17 year old patient) - recommended to be administered in a starting dose of 10 mg 1 p / day daily; MoU - 20 mg 1 g / day daily.